Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications

被引：60

作者：

Poulter, NR ^{[1
]}

Chang, CL

Farley, TMM

Meirik, O

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Clin Pharmacol, Cardiovasc Studies Unit, London W2 1PG, England

[2] WHO, UNDP UNFPA World Bank WHO Special Programme Res D, CH-1211 Geneva, Switzerland

来源：

LANCET | 1999年 / 354卷 / 9190期

关键词：

D O I：

10.1016/S0140-6736(99)03132-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Data from the WHO Collaborative Study suggest that use of progestagen preparations with therapeutic indications are associated with a significantly increased risk of venous thromboembolism but not stroke or myocardial infarction.

引用

页码：1610 / 1610

页数：1